Odyssey, an artificial intelligence lab building world models, today announced it has raised $310 million in early-stage funding at a $1.45 billion valuation. Natural Capital led, and Amazon.com Inc., ...

Weight loss jabs could “transform how we think about cancer prevention”, experts have said after a study linked the medication to a reduced risk of cancers connected with obesity. The study suggested ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

At 3DExperience 2026, SolidWorks introduced AI companions Aura, Leo and Marie, set for release in summer. Live demonstrations showcased AI converting 2D sketches into 3D models within seconds, ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture alliance via Getty Images) ...

LONDON, May 13 (Reuters) - Libya aims to restart its 220,000 barrel-per-day Ras Lanuf oil refinery within six to 12 months ‌to supply the domestic market, National Oil Corporation (NOC) chairman ...

They called it a “geriatric ghetto” and “God’s waiting room.” The sidewalks were cracked, the buildings were run-down and the population of Miami Beach’s South Beach neighborhood in the early 1980s ...

Krutrim, India’s first GenAI unicorn, is shifting from AI model development to cloud services after months of relative quiet on product updates — a move that reflects the tougher economics of building ...

State Appointed Superintendent Mike Miles answers questions about Future 2 Schools at a Virtual Question and Answer event held by the district. Houston ISD has earmarked seven more elementary and ...

After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step into the red-hot cancer field. The Chicago pharma has agreed to ...